RT

Russelmuhammed Thekkullathil

Active Director Managing Director DIN 06593199
DIN 06593199 First appointment Jun 2013 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 2 historical roles
Total affiliations 7 Since Jun 2013
Shareholding value •••• Premium profile

About Russelmuhammed Thekkullathil

Data last updated:

Russelmuhammed Thekkullathil is a Managing Director at R-Cell Lifecell Diagnostics & Research Centre Private Limited (since 2024), Director at Care Grid Healthtech Private Limited (since 2026) and Designated Partner at Astranucleus Llp (since 2025), and holds 2 more current directorships. The companies operate in Paper and Healthcare. The largest current company by reported revenue is R-Cell Lifecell Diagnostics & Research Centre Private Limited at ₹3.51 Cr (FY 2025). Earlier, Russelmuhammed Thekkullathil was a Designated Partner at Thanal Healthcare Llp (from 2018) and Director at 8C Retail Solutions Private Limited (from 2013).

DIN 06593199
Primary Designation Managing Director
Industry Paper
First Appointment 20 Jun 2013
Oldest Company Age 13 yrs
Largest company R-Cell Lifecell Diagnostics & Research Centre Private Limited · ₹3.51 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director19 Sep 20242024₹3.51 Cr (FY 2025)Active
Care Grid Healthtech Private Limited U86900KL2026PTC105357
Director05 Aug 20262026Active
Astranucleus Llp ACT-6135
Designated Partner18 Dec 20252025Active
Designated Partner09 Dec 20252025Active
Designated Partner22 Nov 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner03 May 20182018Strike Off
8C Retail Solutions Private Limited U52100KL2013PTC034356
Director20 Jun 20132013₹86,985 (FY 2016)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Thanal Healthcare Llp
8C Retail Solutions Private Limited
Astranucleus Llp
Firstmed Vims Llp
Premium access

Shareholding and investment profile for Russelmuhammed Thekkullathil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Russelmuhammed Thekkullathil

Russelmuhammed Thekkullathil currently holds 5 directorships: R-Cell Lifecell Diagnostics & Research Centre Private Limited (Managing Director, since 19 Sep 2024, revenue ₹3.51 Cr (FY 2025)); Care Grid Healthtech Private Limited (Director, since 05 Aug 2026); Astranucleus Llp (Designated Partner, since 18 Dec 2025); Firstmed Vims Llp (Designated Partner, since 09 Dec 2025); First Med Nucleus Llp (Designated Partner, since 22 Nov 2023).

Russelmuhammed Thekkullathil was first appointed on 20 Jun 2013 as Director at 8C Retail Solutions Private Limited. The most recent appointment on record is 05 Aug 2026 at Care Grid Healthtech Private Limited.

Russelmuhammed Thekkullathil held 2 earlier board appointments: Thanal Healthcare Llp (Designated Partner, from 03 May 2018); 8C Retail Solutions Private Limited (Director, from 20 Jun 2013).

The current boards of Russelmuhammed Thekkullathil's companies include Abhaya Mayur (R-Cell Lifecell Diagnostics & Research Centre Private Limited), Alok Dadhich (R-Cell Lifecell Diagnostics & Research Centre Private Limited), Deepak Abhayakumar (R-Cell Lifecell Diagnostics & Research Centre Private Limited), Manish Sureka (R-Cell Lifecell Diagnostics & Research Centre Private Limited), Rajul Thekkullathil Veettil (R-Cell Lifecell Diagnostics & Research Centre Private Limited), Shabeer Ali Pathoor (R-Cell Lifecell Diagnostics & Research Centre Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available